In the BioHarmony Drug Report Database

"Preview" Icon

Fosnetupitant

Akynzeo (fosnetupitant) is a small molecule pharmaceutical. Fosnetupitant was first approved as Akynzeo on 2018-04-19. It is known to target substance-P receptor. Akynzeo’s patents are valid until 2037-06-02 (FDA).

 

Trade Name

 

Akynzeo
 

Common Name

 

fosnetupitant
 

ChEMBL ID

 

CHEMBL3989917
 

Indication

 

 

Drug Class

 

Tachykinin (neurokinin) receptor antagonists: NK1 receptor antagonists; phosphoro-derivatives

Image (chem structure or protein)

Fosnetupitant structure rendering